切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2022, Vol. 16 ›› Issue (01) : 32 -35. doi: 10.3877/cma.j.issn.1674-3946.2022.01.011

论著

螺纹扩肛器应用于自然腔道取标本手术治疗超低位直肠癌的安全性及优势
李明晋1,(), 王召辉1, 何金洲1   
  1. 1. 638000 四川广安,广安市人民医院普外二科
  • 收稿日期:2021-03-11 出版日期:2022-02-26
  • 通信作者: 李明晋

The safety and advantages of using threaded anal reamer in natural cavity sampling operation for ultra-low rectal cancer

Mingjin Li1,(), Zhaohui Wang1, Jinzhou He1   

  1. 1. Second Department of general surgery, Guangan People’s Hospital Guang’an, Guangan Sichuan Province 638001, China
  • Received:2021-03-11 Published:2022-02-26
  • Corresponding author: Mingjin Li
  • Supported by:
    Health Research Project of Sichuan Province(18PJ393); Sichuan Medical Youth Innovation Project(Q19048)
引用本文:

李明晋, 王召辉, 何金洲. 螺纹扩肛器应用于自然腔道取标本手术治疗超低位直肠癌的安全性及优势[J]. 中华普外科手术学杂志(电子版), 2022, 16(01): 32-35.

Mingjin Li, Zhaohui Wang, Jinzhou He. The safety and advantages of using threaded anal reamer in natural cavity sampling operation for ultra-low rectal cancer[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2022, 16(01): 32-35.

目的

探讨螺纹扩肛器应用于自然腔道取标本手术(NOSES)治疗超低位直肠癌的安全性及优势。

方法

回顾性分析2017年5月至2019年8月70例超低位直肠癌手术患者的临床资料,根据术式不同将患者分为两组,Bacon组行改良Bacon术经自然腔道取标本,扩肛器组应用螺纹扩肛器完成经自然腔道取标本术,每组各35例。采用软件SPSS 23.0进行统计学分析。围手术期指标、肛门功能评分(Wexner、Vaizey评分)等计量资料以(

xˉ
±s)表示,采用独立样本t检验;术后并发症等计数资料采用χ2检验;P<0.05表示差异有统计学意义。

结果

Bacon组手术时间明显低于扩肛器组(P<0.05),而扩肛器组术中出血量、术后首次排气时间、住院时间均优于改良Bacon组(P<0.05);两组患者淋巴结清扫数目差异无统计学意义(P>0.05);术后6个月和12个月,两组患者Wexner评分、Vaizey评分均有所降低,肛门功能逐渐恢复,且扩肛器组评分均显著低于Bacon组(P<0.05);术后扩肛器组总并发症发生率明显低于改良Bacon组(5.7% vs. 22.9%,P<0.05);截止2020年9月,所有患者平均随访时间(15.2±2.8)个月,两组患者均未发生肿瘤复发或转移。

结论

超低位直肠癌手术应用螺纹扩肛器于自然腔道取标本,可明显减少并发症的发生,降低术中出血量,对保留患者肛门括约肌,提升术后肛门功能有显著效果。

Objective

To investigate the safety and advantages of screw-thread anal dilator in the treatment of ultra-low rectal cancer in natural orifice specimen extraction surgery(NOSES).

Methods

The clinical data of 70 patients undergoing surgery for ultra-low rectal cancer from May 2017 to August 2019 were retrospectively analyzed. The patients were divided into two groups according to different surgical methods:Bacon group underwent improved Bacon method of sampling through natural cavity,and the anal dilator group underwent threaded anal dilator to complete the natural cavity,with 35 cases in each group.SPSS23.0 was used for statistical analysis. Perioperative indexes,anal function score(Wexner,Vaizey score)and other measurement data were expressed as(

xˉ
±s),and independent t test was used. Postoperative complications were analyzed by χ2 test. P<0.05 indicated statistically significant difference.

Results

The operation time of the Bacon group was significantly lower than that of the anal dilator group(P<0.05),while the intraoperative blood loss,first exhaust time and hospital stay of the anal dilator group were better than those of the improved Bacon group.(P<0.05).There was no significant difference in the number of lymph node dissection between the two groups(P>0.05). At 6and 12 months after surgery,Wexner score and Vaizey score were decreased,anal function gradually recovered,and the scores of the anal expander group were significantly lower than that of Bacon group(P<0.05).The incidence of postoperative complications in the anal reamer group was significantly lower than that in the modified Bacon group(5.7% vs. 22.9%,P<0.05).By September 2020,all patients were followed up,with an average follow-up time of(15.2 ± 2.8)months. No tumor recurrence or metastasis occurred in both groups.

Conclusion

The application of threaded anal reamer in the natural cavity for the operation of ultra-low rectal cancer can significantly reduce the occurrence of complications,reduce the amount of intraoperative blood loss,preserve the anal sphincter of patients and improve the postoperative anal function.

表1 70例超低位直肠癌不同术式两组患者基线资料比较[(
xˉ
±s),例]
表2 70例超低位直肠癌不同术式两组患者围手术期相关指标比较(
xˉ
±s
表3 70例超低位直肠癌不同术式两组患者术后肛门功能比较[(
xˉ
±s),分]
表4 70例超低位直肠癌不同术式两组患者术后并发症比较[例(%)]
[1]
Paty PB,,Cercek A,,Crane CH. Reducing the morbidity of rectal cancer treatment[J]. JAMA Oncol20195(7):940-941.
[2]
谢爽,张春旭,尹智渊,等. 改良腹腔镜肛提肌外腹会阴联合切除术治疗超低位直肠癌的近期疗效[J]. 中华消化外科杂志202019(10):1091-1097.
[3]
Li Q,,Li D,,Jiang L,et al. Factors Influencing Difficulty of Laparoscopic Abdominoperineal Resection for Ultra-Low Rectal Cancer[J]. Surg Laparosc Endosc Percutan Tech201727(2):104-109.
[4]
Yu S,,Deng J,,Luo T,et al. Study of anorectal dynamics in patients undergoing laparoscopic ultra-low resection and transanal intersphincteric resection for rectal cancer[J]. ANZ J Surg202090(12):2478-2483.
[5]
Lu Z,,Chen H,,Zhang M,et al. Safety and survival outcomes of transanal natural orifice specimen extraction using prolapsing technique for patients with middle- to low-rectal cancer[J]. Chin J Cancer Res202032(5):654-664.
[6]
刘李,杨烈,杨柳,等. 腹腔镜下改良Bacon’s直肠癌根治术对患者术后肛门功能与远期疗效观察[J/CD]. 中华普外科手术学杂志(电子版)202014(1):46-49.
[7]
蒋鸿元,李亚平,朱明杰,等. 不同手术操作方式在直肠癌NOSES手术中的临床应用研究[J/CD].中华普外科手术学杂志(电子版)202014(4):350-353.
[8]
Bjoern MX,,Nielsen S,,Perdawood SK. Quality of Life After Surgery for Rectal Cancer:a Comparison of Functional Outcomes After Transanal and Laparoscopic Approaches[J]. J Gastrointest Surg201923(8):1623-1630.
[9]
王清奎,吉丙阳. 腹腔镜经肛拖出根治术与传统开腹切除术治疗中低位直肠癌的临床比较[J/CD]. 中华普外科手术学杂志(电子版)201913(4):396-399.
[10]
Jayne D,,Pigazzi A,,Marshall H,et al. Effect of robotic-assisted vs conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal Cancer:the ROLARR Randomized Clinical Trial[J]. JAMA2017318(16):1569-1580.
[11]
Peng B,,Lu J,,Wu Z,et al. Intersphincteric Resection Versus Abdominoperineal Resection for Low Rectal Cancer:A Meta-Analysis[J]. Surg Innov202027(4):392-401.
[12]
Paty PB,,Cercek A,,Crane CH. Reducing the morbidity of rectal cancer treatment[J]. JAMA Oncol20195(7):940-941.
[13]
2017 European Society of Coloproctology(ESCP)collaborating group. An international multicentre prospective audit of elective rectal cancer surgery;operative approach versus outcome,including transanal total mesorectal excision(TaTME)[J]. Colorectal Dis201820(suppl 6):33-46.
[14]
江波,卢艳军,刘海义,等. 经自然腔道取标本改良Bacon术在低位直肠癌中的应用[J]. 腹腔镜外科杂志201823(11):827-830.
[15]
庄成乐,张现中,刘骞,等. 基于一种螺纹扩肛器的超低位直肠癌精准保肛(PPS)手术[J/CD]. 中华结直肠疾病电子杂志20198(5):509-512.
[1] 贺敬龙, 尚宏喜, 郝敏, 谢伟, 高明宏, 孙炜, 刘安庆. 重度类风湿关节炎患者行多关节置换术的临床手术疗效[J]. 中华关节外科杂志(电子版), 2023, 17(06): 860-864.
[2] 代莉, 邓恢伟, 郭华静, 黄芙蓉. 术中持续输注艾司氯胺酮对腹腔镜结直肠癌手术患者术后睡眠质量的影响[J]. 中华普通外科学文献(电子版), 2023, 17(06): 408-412.
[3] 王得晨, 杨康, 杨自杰, 归明彬, 屈莲平, 张小凤, 高峰. 结直肠癌微卫星稳定状态和程序性死亡、吲哚胺2,3-双加氧酶关系的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 462-465.
[4] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[5] 张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[6] 张焱辉, 张蛟, 朱志贤. 留置肛管在中低位直肠癌新辅助放化疗后腹腔镜TME术中的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 25-28.
[7] 李婷, 张琳. 血清脂肪酸代谢物及维生素D水平与结直肠癌发生的关系研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 661-665.
[8] 汤海琴, 郭秀枝, 朱晓素, 赵世娣. “隧道法”腹腔镜解剖性左半肝切除术的临床安全性研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 674-677.
[9] 付振保, 曹万龙, 刘富红. 腹腔镜直肠癌低位前切除术中不同缝合方法的回肠双腔造口术临床效果研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 684-687.
[10] 贺亮, 王松林, 周业江. 两种预防性回肠造口在腹腔镜ISR术治疗超低位直肠癌的效果对比研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 697-700.
[11] 关旭, 王锡山. 基于外科与免疫视角思考结直肠癌区域淋巴结处理的功与过[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 448-452.
[12] 顾睿祈, 方洪生, 蔡国响. 循环肿瘤DNA检测在结直肠癌诊治中的应用与进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 453-459.
[13] 张继新, 胡军红, 谢爽, 武祖印, 张春旭. 经阴道单孔腹腔镜阑尾切除术可行性及近期疗效分析[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 460-465.
[14] 卢艳军, 马健, 白鹏宇, 郭凌宏, 刘海义, 江波, 白文启, 张毅勋. 纳米碳在腹腔镜直肠癌根治术中253组淋巴结清扫的临床效果[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 473-477.
[15] 梁文龙, 曹杰, 黄庆, 林泳, 黄红丽, 杨平, 李冠炜, 胡鹤. 信迪利单抗联合瑞戈非尼治疗晚期结直肠癌的疗效与安全性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 409-413.
阅读次数
全文


摘要